How Long Ipamorelin Stays in Your System: Half-Life

The short answer

How long does ipamorelin stay in your system? In the one human study that measured it, the terminal half-life — the time for the blood level to drop by half once it starts clearing — was about two hours ^[2]. A useful rule of thumb in pharmacology is that a drug is mostly gone after four to five half-lives, which for ipamorelin works out to roughly eight to ten hours before the blood level falls to a small fraction of its peak. That is the drug clearing. The effect — a single burst of growth hormone — is even shorter-lived, peaking around forty minutes after a dose and then subsiding ^[2]. So the honest answer has two parts: the peptide itself is cleared within hours, and the hormone pulse it causes is briefer still. Every number on this page traces back to the same human pharmacokinetic study.

The terminal half-life: about 2 hours

The figure comes from population pharmacokinetic-pharmacodynamic modeling in healthy male volunteers, n=8 per dose level, given five 15-minute intravenous infusions spanning 4.21 to 140.45 nmol/kg. The kinetics were linear and dose-proportional, and the terminal half-life was approximately 2 hours ^[2]. Dose-proportional means doubling the dose roughly doubled the exposure without changing the half-life — a clean, predictable profile.

This is an intravenous half-life. By the subcutaneous route that dominates community use, the absorption phase adds time at the front end, so the apparent duration can be longer than the pure 2-hour elimination figure — but no controlled human subcutaneous pharmacokinetic study has characterized that, so the only defensible human half-life number remains the ~2-hour intravenous value ^[2].

Clearance and volume of distribution

Two further parameters fill in the picture. Plasma clearance — how much blood is fully cleared of the drug per unit time — was 0.078 L/h/kg, and the steady-state volume of distribution was 0.22 L/kg ^[2]. A volume of distribution near 0.2 L/kg is small, roughly consistent with the compound staying largely in the extracellular fluid rather than distributing widely into tissues, which fits a small, water-soluble peptide.

In rats, plasma clearance is roughly 5-fold lower than that of GHRP-6, a related peptide — a comparative note that helps place ipamorelin's handling within its class ^[2]. Together, the half-life, clearance, and volume figures are the quantitative core of any due-diligence reading of how the body processes ipamorelin.

Detection is a separate question from clearance

"Stays in your system" can mean two different things: how long the compound exerts an effect, and how long a laboratory can detect it. These are not the same. While the active half-life is about 2 hours, accredited anti-doping laboratories can detect ipamorelin and its metabolites in urine using sensitive methods — direct-urine-injection ion-mobility mass spectrometry achieves limits of detection of 50-500 pg/mL ^[12], and ipamorelin's urinary metabolite pattern after administration has been characterized ^[10]. Detection windows depend on dose, route, and assay sensitivity and are not the same as the pharmacokinetic half-life. For anyone subject to anti-doping testing, the relevant point is that ipamorelin is prohibited at all times under WADA category S2 and is reliably detectable, well after its pharmacological effect has passed.